Jackson Memorial Hospital
Miami, Florida 33236
10 studies enrolling now · 107 studies all time
What they study most
AIDS, Acute Antibody-Mediated Rejection (AMR), Acute Ischemic Stroke, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Pain, Airway Obstruction, Alcohol Abuse, Anaplastic Astrocytoma, Anemia, Anemia, Sickle Cell, Anesthesia
Studies at this site
- Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System — Recruiting now
- Strategy for Improving Stroke Treatment Response — Recruiting now
- Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition — Recruiting now
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
- CoMind Early Feasibility Study — Recruiting now
- Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age — Recruiting now
- StrokeNet Thrombectomy Endovascular Platform — Recruiting now
- Systemic Hypothermia in Acute Cervical Spinal Cord Injury — Recruiting now
- The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE — Recruiting now
- The EBC Recovery Study — Recruiting now
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
- A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants — Running, not enrolling
- Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF ) — Completed
- Treatment (Compassionate) Use of Device - PK Papyrus — TEMPORARILY_NOT_AVAILABLE
- C-Cog in Early Course Schizophrenia Study — Stopped early
- Sleep for Stroke Management and Recovery Trial — Running, not enrolling
- The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days — Stopped early
- Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
- Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 — Completed
- Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 — Stopped early
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
- Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure — Stopped early
- Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE) — Stopped early
- HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission — Completed
- Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
- Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions — Completed
- Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study — Completed
- Multi-arm Optimization of Stroke Thrombolysis — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
- Emergency Department-Initiated Buprenorphine Validation Network Trial — Completed
- HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option — NO_LONGER_AVAILABLE
- Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure — Stopped early
- Audio Distraction for Traction Pin Placement — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) — Completed
- Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries — APPROVED_FOR_MARKETING
- Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV — Status unconfirmed
- Tenecteplase in Stroke Patients Between 4.5 and 24 Hours — Completed
- Transitions of Care Stroke Disparity Study (TCSD-S) — Completed
- Remote Ischemic PreConditioning (RIPC) — Withdrawn before enrolling
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) — Completed
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) — Completed
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) — Completed
- hCT-MSCs for COVID19 ARDS — Stopped early
- Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 — Completed
- Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up — Completed
- Family Automated Voice Reorientation Study — Completed
- Convalescent Plasma in Outpatients With COVID-19 — Completed